Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata prefer effective, safe, and convenient treatments, especially topical ones.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Psychological therapies may improve quality of life for people with alopecia areata.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The representation of skin conditions in medical reviews partly matches their real-world impact.

Finasteride significantly improves hair growth but may cause sexual side effects.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Alopecia areata affects women and young adults most, with low SDI regions seeing the highest increase, and new treatments like JAK inhibitors are being explored.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

Interest in Acanthosis nigricans research is growing, highlighting key focus areas and influential work.

Keratin 17 is important for skin's response to radiation, affecting many genes and cell division.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

Alopecia areata is decreasing globally, affects more females, and is linked to anxiety and atopic dermatitis, especially in children.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

Tertiary lymphoid structures are important in immunotherapy and need more research.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

Research on platelet-rich plasma is growing, focusing on joint repair and future trends in pain and regenerative medicine.

EV-based therapies are advancing but need to overcome challenges for full potential.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

The USA, China, Italy, and Türkiye lead in diverse PRP research, focusing on healing and pain management.